57A-62687-29805
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 900 / CA
- Registered
- 2021-06-21
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
-
2021-06-21
Registered in v-safe
-
2021-07-10
Survey response — 3 months, dose 1MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Runny nose and congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-09
-
2022-03-23
Dose 2 — Pfizer-BioNTech
- 2022-04-10
- 2022-04-10
- 2022-04-13
-
2022-04-22
Survey response — day 28, dose 2MedDRA: Dyspnoea, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion I can't breathe sometimesMedDRA releases: 2024-11 · check-in free text available
- 2022-04-27
- 2022-05-04
- 2022-06-22
- 2022-09-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson | No |
| 2 | 2022-03-23 | Pfizer-BioNTech | No |
Free text
Release 9 — 3 months, dose 1
Symptoms: Runny nose and congestion
Release 11 — day 28, dose 2
Symptoms: Congestion I can't breathe sometimes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release